Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.
Journal: Journal of child neurology
Published: September 16, 2025
Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS.
Journal: Neurodegenerative disease management
Published: July 15, 2025
Efficacy and safety of disease-modifying therapies in pediatric-onset multiple sclerosis: A systematic review of clinical trials and observational studies.
Journal: Multiple sclerosis and related disorders
Published: September 17, 2024
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY).
Journal: Multiple sclerosis and related disorders
Published: June 01, 2024
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 24, 2023
Impact of interferon beta exposure on birth outcome and child development - Results from the post-authorisation safety study PRIMA.
Journal: Multiple sclerosis and related disorders
Published: March 22, 2023
Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: March 03, 2023
Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme - results from the non-interventional post-authorization safety study PRIMA.
Journal: Therapeutic advances in neurological disorders
Published: December 16, 2022
Recurrent encephalopathy associated with pegylated beta-interferon treatment.
Journal: Journal of neuroimmunology
Published: September 08, 2022
Multiple sclerosis clinical decision support system based on projection to reference datasets.
Journal: Annals of clinical and translational neurology
Published: April 07, 2022
Standard Dose Weekly Intramuscular Beta Interferon-1a May Be Inadequate for Some Patients with Multiple Sclerosis: A 19-Year Clinical Experience Using Twice a Week Dosage.
Journal: Neurology and therapy
Published: February 22, 2022
Last Updated: 10/31/2025